Kongressberichte & Archiv

Cancer Center Zürich Second - Zurich Immuno-Oncology Symposium

Essentials of tumour immunology and immunotherapies

Essentials of tumour immunology and immunotherapies

– Maries van den Broek: Tumour immunology

– John Haanen: Combination of immune checkpoints

– Discussion

News

TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial

31-01-2020 22:56
The combination of TAS-102 plus bevacizumab could be a new treatment option for patients with refractory metastatic colorectal cancer and could be a practice-changing development (cited in the Lancet Oncology)
Weiterlesen ...
TRENDING NOW ON JAMA ONCOLOGY:

09-01-2020 17:50
Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Breast Cancer That Progressed on Endocrine Therapy
Establishing a SAKK Working Group for Cellular Therapies

19-12-2019 22:08
PRESS RELEASE
Date Bern, December 12, 2019
Weiterlesen ...